SARS-CoV-2 Variant Warning: India’s Double Mutant Variant B.1.617 Is More Vicious As Autopsy Study Shows. Countries Should Ban All Indian Travellers!
SARS-CoV-2 Variant Warning
: The Indian double mutant variant called B.1.617
that contains the L452R and E484Q mutations along with a variety of other mutations is fast spreading not only in India but has now already been found in other countries including United Kingdom, the United States and even in a variety of South-East Asian countries including one that is the financial hub of the region and another that has been under the most corrupted and incompetent military dictatorship over the past few years. (The authorities in both South-East Asian countries are however shielding the public from knowing the truth while still allowing Indian travellers and workers to still flow into the country!)
While the WHO has yet to upgrade the B.1.617 to that of the status of a VOC or variant of concern (Nothing can be expected from the agency that has so far been responsible for the escalation of the pandemic due to their incompetency!), the virus has also shown to not only be more infectious and transmissible but also causing progression of disease severity much faster along with indications that the virus could be more potent and vicious in the way it attacks the human host body compared to other strains.
A latest Indian autopsy study that has yet to be published conducted by a post-mortem on a 68-year-old female COVID-19 patient, who died on April 5 in a metropolis hospital, has revealed that her very important organs – lungs, mind and kidneys – had been attacked extensively though she had tested negative on the twelfth day. The post-mortem revealed that the reason for demise on this case was acute myocardial infarction.
This post-mortem, the second within the Bengaluru metropolis, was executed on April 7 by Dr Dinesh Rao, who heads the Department of Forensic Medicine in Oxford Medical College and Research Institute-Bengaluru.
He told Thailand Medical news, “We did the autopsy following a request from the patient’s son as he wanted to know the exact cause of death.”
The patient, who was admitted for 3 days, was suggested dwelling isolation regardless of her comorbidities ie diabetes and hypertension.
But however, the patient developed respiratory issues after 12 days and was rushed to the hospital once more when she examined negative. She died on April 5.
Dr Rao added, “Unlike in the first autopsy on a 62-year-old patient in October last year when RT-PCR swabs revealed the virus was active in the mouth, throat and nasal area 18 hours after death, the swabs from six regions in this second body were RT-PCR negative. But her lungs, brain and kidneys were extensively damaged.”
Dr Rao further added, “She had developed lung fibrosis and together both the lungs weighed around 900 grams. The virus that had infected her brain and kidneys could not be detected by RT-PCR.”
He further added, “Her comorbidities were the underlying causes, while COVID-19 was the main factor. The RT-PCR negative reports of the six swabs indicate the possibility of different mutated strains of the virus or the delay in postmortem sampling.”
Further sequencings revealed that the patient was in
fected with the B.1.617 strain.
Leading Indian virologist Dr V. Ravi, who’s the nodal officer for genomic affirmation of SARS-CoV-2 in Karnataka stated RT-PCR assessments utilized in India don’t miss the U.K., Brazil, South Africa or the double mutant variants of the virus as they aim greater than two genes. “This autopsy shows that the patient dies of post-COVID-19 complications.” Dr. Ravi added.
Readers should be aware that there is a concerted effort by certain individuals and entities with vested interests to make sure that the public is not made aware of the seriousness of emerging variants and also the long term effects of COVID-19 and also the impacts of the coming waves despite the massive vaccination programmes underway.
Thailand Medical News will be providing further reports on the B.1.617